-
1
-
-
0022406658
-
Photoaffinity labeling of the progesterone receptor from human endometrial carcinoma
-
CLARKE, C.L. and SATYASWAROOP, P.G., Photoaffinity labeling of the progesterone receptor from human endometrial carcinoma. Cancer Res., 45, 5417-5420 (1985).
-
(1985)
Cancer Res.
, vol.45
, pp. 5417-5420
-
-
Clarke, C.L.1
Satyaswaroop, P.G.2
-
3
-
-
0031964105
-
Comparison of the effects of the antiestrogens EM-800 and tamoxifen on the growth of human breast ZR-75-1 cancer xenografts in nude mice
-
COUILLARD, S., GUTMAN, M., LABRIE, C., BELANGER, A., CANDAS, B. and LABRIE, F., Comparison of the effects of the antiestrogens EM-800 and tamoxifen on the growth of human breast ZR-75-1 cancer xenografts in nude mice. Cancer Res., 58, 60-64 (1998).
-
(1998)
Cancer Res.
, vol.58
, pp. 60-64
-
-
Couillard, S.1
Gutman, M.2
Labrie, C.3
Belanger, A.4
Candas, B.5
Labrie, F.6
-
4
-
-
0025807616
-
Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice
-
DAUVOIS, S., GENG, C.S., LEVESQUE, C., MERAND, Y. and LABRIE, F., Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice. Cancer Res., 51, 3131-3135 (1991).
-
(1991)
Cancer Res.
, vol.51
, pp. 3131-3135
-
-
Dauvois, S.1
Geng, C.S.2
Levesque, C.3
Merand, Y.4
Labrie, F.5
-
5
-
-
0027362482
-
Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer
-
FORNANDER, T., HELLSTROM, A.C. and MOBERGER, B., Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer. J. nat. Cancer Inst., 85, 1850-1855 (1993).
-
(1993)
J. Nat. Cancer Inst.
, vol.85
, pp. 1850-1855
-
-
Fornander, T.1
Hellstrom, A.C.2
Moberger, B.3
-
6
-
-
0021618186
-
The pharmacology and clinical uses of tamoxifen
-
FURR, B.J. and JORDAN, V.C., The pharmacology and clinical uses of tamoxifen. Pharmacol. Ther., 25, 127-205 (1984).
-
(1984)
Pharmacol. Ther.
, vol.25
, pp. 127-205
-
-
Furr, B.J.1
Jordan, V.C.2
-
7
-
-
0030793285
-
(S)-(+)-4-7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl) ethoxy[phenyl]-2H-1-benzopyran-3-yl]-phenyl] 2,2-dimethylpropanoate (EM-800): A highly potent, specific, and orally active non steroidal antiestrogen
-
GAUTHIER, S. and 15 OTHERS, (S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl) ethoxy[phenyl]-2H-1-benzopyran-3-yl]-phenyl] 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active non steroidal antiestrogen. J. med. Chem., 40, 2117-2122 (1997).
-
(1997)
J. Med. Chem.
, vol.40
, pp. 2117-2122
-
-
Gauthier, S.1
-
8
-
-
0024319781
-
Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens
-
GOTTARDIS, M.M., JIANG, S.Y., JENG, M.H. and JORDAN, V.C., Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens. Cancer Res., 49, 4090-4093 (1989).
-
(1989)
Cancer Res.
, vol.49
, pp. 4090-4093
-
-
Gottardis, M.M.1
Jiang, S.Y.2
Jeng, M.H.3
Jordan, V.C.4
-
9
-
-
0023915865
-
Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse
-
GOTTARDIS, M.M., ROBINSON, S.P., SATYASWAROOP, P.G. and JORDAN, V.C., Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Cancer Res., 48, 812-815 (1988).
-
(1988)
Cancer Res.
, vol.48
, pp. 812-815
-
-
Gottardis, M.M.1
Robinson, S.P.2
Satyaswaroop, P.G.3
Jordan, V.C.4
-
10
-
-
0002805823
-
Endocrine therapy in metastatic breast cancer
-
J.R. Harris, S. Hellman, I.C. Henderson and D.W. Kinne (eds.), J.B. Lippincott, Philadephia
-
HENDERSON, I., Endocrine therapy in metastatic breast cancer. In J.R. Harris, S. Hellman, I.C. Henderson and D.W. Kinne (eds.), Breast diseases, p. 398, J.B. Lippincott, Philadephia (1987).
-
(1987)
Breast Diseases
, pp. 398
-
-
Henderson, I.1
-
11
-
-
0030016280
-
Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer
-
HOWELL, A., DEFRIEND, D.J., ROBERTSON, J.F., BLAMEY, R.W., ANDERSON, L., ANDERSON, E., SUTCLIFFE, F.A. and WALTON, P., Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer. Brit. J. Cancer, 74, 300-308 (1996).
-
(1996)
Brit. J. Cancer
, vol.74
, pp. 300-308
-
-
Howell, A.1
Defriend, D.J.2
Robertson, J.F.3
Blamey, R.W.4
Anderson, L.5
Anderson, E.6
Sutcliffe, F.A.7
Walton, P.8
-
12
-
-
0026768801
-
Response after withdrawal of tamoxifen and progestogens in advanced breast cancer
-
HOWELL, A., DODWELL, D.J., ANDERSON, H. and REDFORD, J., Response after withdrawal of tamoxifen and progestogens in advanced breast cancer. Ann. Oncol., 3, 611-617 (1992).
-
(1992)
Ann. Oncol.
, vol.3
, pp. 611-617
-
-
Howell, A.1
Dodwell, D.J.2
Anderson, H.3
Redford, J.4
-
13
-
-
0025892130
-
The effect of anti-oestrogens on cell growth and progesterone receptor concentration in human endometrial cancer cells (Ishikawa)
-
JAMIL, A., CROXTALL, J.D. and WHITE, J.O., The effect of anti-oestrogens on cell growth and progesterone receptor concentration in human endometrial cancer cells (Ishikawa). J. mol. Endocrinol., 6, 215-221 (1991).
-
(1991)
J. Mol. Endocrinol.
, vol.6
, pp. 215-221
-
-
Jamil, A.1
Croxtall, J.D.2
White, J.O.3
-
14
-
-
0026571802
-
Novel compounds inhibit estrogen formation and action
-
LABRIE, C., MARTEL, C., DUFOUR, J.M., LEVESQUE, C., MERAND, Y. and LABRIE, F., Novel compounds inhibit estrogen formation and action. Cancer Res., 52, 610-615 (1992).
-
(1992)
Cancer Res.
, vol.52
, pp. 610-615
-
-
Labrie, C.1
Martel, C.2
Dufour, J.M.3
Levesque, C.4
Merand, Y.5
Labrie, F.6
-
16
-
-
0033006836
-
Cancer statistics, 1999
-
LANDIS, S.H., MURRAY, T., BOLDEN, S. and WINGO, P.A., Cancer statistics, 1999. CA Cancer J. Clin., 49, 8-31 (1999).
-
(1999)
CA Cancer J. Clin.
, vol.49
, pp. 8-31
-
-
Landis, S.H.1
Murray, T.2
Bolden, S.3
Wingo, P.A.4
-
17
-
-
0002269686
-
Estrogen receptors in human breast cancer: An overview
-
W.L. McGuire, P.P. Carbone and E.P. Vollmer (eds.), Raven Press, New York
-
MCGUIRE, W.L., CARBONE, P.P., SEARD, M.E. and ESCHE, G.C., Estrogen receptors in human breast cancer: an overview. In W.L. McGuire, P.P. Carbone and E.P. Vollmer (eds.), Estrogen receptors in human breast cancer, pp. 1-7, Raven Press, New York (1975).
-
(1975)
Estrogen Receptors in Human Breast Cancer
, pp. 1-7
-
-
McGuire, W.L.1
Carbone, P.P.2
Seard, M.E.3
Esche, G.C.4
-
18
-
-
0029075872
-
Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer
-
OSBORNE, C.K., CORONADO HEINSOHN, E.B., HILSENBECK, S.G., MCCUE, B.L., WAKELING, A.E., MCCLELLAND, R.A., MANNING, D.L. and NICHOLSON, R.I., Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer. J. nat. Cancer Inst., 87, 746-750 (1995).
-
(1995)
J. Nat. Cancer Inst.
, vol.87
, pp. 746-750
-
-
Osborne, C.K.1
Coronado Heinsohn, E.B.2
Hilsenbeck, S.G.3
McCue, B.L.4
Wakeling, A.E.5
McClelland, R.A.6
Manning, D.L.7
Nicholson, R.I.8
-
19
-
-
0022401501
-
Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay
-
OSBORNE, C.K., VON HOFF, D.D. and MULLINS, K., Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay. Breast Cancer Res. Treat., 6, 229-235 (1985).
-
(1985)
Breast Cancer Res. Treat.
, vol.6
, pp. 229-235
-
-
Osborne, C.K.1
Von Hoff, D.D.2
Mullins, K.3
-
20
-
-
0030879732
-
Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro
-
SIMARD, J., LABRIE, C., BELANGER, A., GAUTHIER, S., SINGH, S.M., MERAND, Y. and LABRIE, E., Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro. Int. J. Cancer, 73, 104-112 (1997a).
-
(1997)
Int. J. Cancer
, vol.73
, pp. 104-112
-
-
Simard, J.1
Labrie, C.2
Belanger, A.3
Gauthier, S.4
Singh, S.M.5
Merand, Y.6
Labrie, E.7
-
21
-
-
0030860885
-
Blockade of the stimulatory effect of estrogens, OH-Tamoxifen, OH-Toremifene, Droloxifene and Raloxifene on alkaline phosphatase activity by the antiestrogen EM-800 in human endometrial adenocarcinoma Ishikawa cells
-
SIMARD, J., SANCHEZ, R., POIRIER, D., GAUTHIER, S., SINGH, S.M., MERAND, Y., BELANGER, A., LABRIE, C. and LABRIE, F., Blockade of the stimulatory effect of estrogens, OH-Tamoxifen, OH-Toremifene, Droloxifene and Raloxifene on alkaline phosphatase activity by the antiestrogen EM-800 in human endometrial adenocarcinoma Ishikawa cells. Cancer Res., 57, 3494-3497 (1997b).
-
(1997)
Cancer Res.
, vol.57
, pp. 3494-3497
-
-
Simard, J.1
Sanchez, R.2
Poirier, D.3
Gauthier, S.4
Singh, S.M.5
Merand, Y.6
Belanger, A.7
Labrie, C.8
Labrie, F.9
-
22
-
-
0023747407
-
Biology and mode of action of pure antiestrogens
-
WAKELING, A.E. and BOWLER, J., Biology and mode of action of pure antiestrogens. J. Steroid Biochem., 30, 141-147 (1988).
-
(1988)
J. Steroid Biochem.
, vol.30
, pp. 141-147
-
-
Wakeling, A.E.1
Bowler, J.2
|